ARRJF - Arjo AB: Low Valuation On Low Expectations
2025-06-04 06:15:00 ET
Summary
- We have built a substantial position in Arjo AB, reversing our prior bearish stance due to its attractive risk/reward profile.
- Arjo's prior growth strategy disappointed, but a management shakeup and renewed focus on efficiency and core business offer turnaround potential.
- Low expectations and valuation, robust free cash flow, and insider buying create a compelling margin of safety for investors.
- Consensus estimates are too low; even meeting expectations could drive a re-rating, with structural options and a strong balance sheet providing downside protection.
The following segment was excerpted from this fund letter.
We have built a substantial position in Swedish medtech company Arjo AB ( ARRJF ) in recent weeks. This is a first for us, as Arjo is a company we have been short on and off for the past few years. We have been critical about strategy, communication, valuation, and capital allocation....
Arjo AB: Low Valuation On Low Expectations